Overview

A Trial of HRS-8427 in the Treatment of Adults With Bacterial Pneumonia

Status:
RECRUITING
Trial end date:
2026-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of HRS -8427 in patients with HABP/VABP.
Phase:
PHASE2
Details
Lead Sponsor:
Jiangsu HengRui Medicine Co., Ltd.
Treatments:
Meropenem